Trial NCT00550420

View at ClinicalTrials.gov 
Org. Study IDs: AVA102677

Last trial update was posted on 2017-11-08

MeSH Interventions

Rosiglitazone

MeSH Conditions

Alzheimer Disease

Other Conditions

Alzheimer's Disease

Stopping Reasons

Based on preliminary parent study results

Limitations And Caveats

The study was early terminated on 12 February 2009 because RSG XR as monotherapy in Alzheimer's disease failed to demonstrate efficacy.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID